About Bugworks Research
Bugworks Research is a company based in Saratoga (United States) founded in 2014 by Santanu Datta and Anand Anandkumar. Bugworks Research has raised $42.89 million across 15 funding rounds from investors including NIH, Baxter and 3one4 Capital. Bugworks Research offers products and services including Antibacterial Agents and Oncology Therapeutics. Bugworks Research operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter Saratoga, United States
- Founders Santanu Datta, Anand Anandkumar
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bugworks Research India Private Limited
- Date of Incorporation 04 Feb, 2014
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$3.34 M (USD)39.83as on Mar 31, 2023
-
Net Profit
$325.47 K (USD)-1as on Mar 31, 2023
-
EBITDA
$987.21 K (USD)26.61as on Mar 31, 2023
-
Total Equity Funding
$42.89 M (USD)
in 15 rounds
-
Latest Funding Round
$6.78 M (USD), Series B
Feb 22, 2024
-
Investors
NIH
& 19 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bugworks Research
Bugworks Research offers a comprehensive portfolio of products and services, including Antibacterial Agents and Oncology Therapeutics.
Novel small molecules targeting multidrug-resistant infections.
Small molecules for hypoxic and refractory solid tumors.
People of Bugworks Research
Unlock access to complete
Unlock access to complete
Funding Insights of Bugworks Research
Bugworks Research has successfully raised a total of $42.89M across 15 strategic funding rounds. The most recent funding activity was a Series B round of $6.78 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bugworks Research
Bugworks Research has secured backing from 20 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include NIH, Baxter and 3one4 Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology sectors like SaaS and Fintech in India.
|
Locked | Locked | Locked | |
|
Global Brain is recognized as a venture capital firm supporting startups.
|
Locked | Locked | Locked | |
|
Seed and Early stage VC firm investing in Japan
|
Locked | Locked | Locked |
Investor details for Bugworks Research
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bugworks Research
Investment portfolio details for Bugworks Research
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bugworks Research
Detailed financials for Bugworks Research
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bugworks Research Comparisons
Peer comparison for Bugworks Research
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bugworks Research
Bugworks Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for cancer and rare diseases are developed.
|
Detailed competitors of Bugworks Research
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bugworks Research
Complete news archive for Bugworks Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bugworks Research
Bugworks Research was founded in 2014.
Bugworks Research is headquartered in Saratoga, United States. It is registered at Saratoga, California, United States.
Anand Anandkumar is the current CEO of Bugworks Research. They have also founded this company.
Bugworks Research is a funded company, having raised a total of $42.89M across 15 funding rounds to date.
Annual revenue of Bugworks Research is $3.34M as on Mar 31, 2023.
Bugworks Research was founded in 2014 in Saratoga, United States, within the biotechnology sector. Therapeutics targeting antibiotic-resistant bacterial infections and cancer are developed using the Microbial Platform (BMP), which models biofilm formation and bacterial behavior. A lead Gyrase-topoisomerase inhibitor is advanced for intravenous and oral treatments of multi-drug resistant infections, with mechanisms that inhibit two replication targets and circumvent bacterial efflux resistance.
Bugworks Research's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Bugworks Research offers Antibacterial Agents and Oncology Therapeutics.
Bugworks Research has 20 investors. Key investors include NIH, Baxter, 3one4 Capital, CARB-X, and UK Research and Innovation.